---
title: "STAAR Surgical Company Stock 12‑Month Price Target Raised to $30.5, Implies 6% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289546217.md"
description: "Analysts have raised the average 12-month price target for STAAR Surgical Company to $30.5, implying a 6% upside from the June 11 closing price. The consensus rating among 11 covering analysts has shifted to 'Buy', comprising 3 Buys and 8 Holds. Price forecasts range from $25 to $40 per share."
datetime: "2026-06-12T04:20:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289546217.md)
  - [en](https://longbridge.com/en/news/289546217.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289546217.md)
generator: "portal-rs"
---

# STAAR Surgical Company Stock 12‑Month Price Target Raised to $30.5, Implies 6% Upside

-   According to estimates from 8 analysts, STAAR Surgical Company stock's average price target has risen from $29.67 to $30.5, with forecasts ranging from $25 to $40 per share
-   Based on the Jun. 11 closing price, the updated target implies approximately 6% potential upside
-   Consensus rating has shifted to “Buy” across 11 covering analysts, with 3 Buys, 8 Holds and 0 Sells

Explore more price target data and ratings for STAAR Surgical Company on the , and track all previous and future analyst recommendations for STAAR Surgical Company in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [STAA.US](https://longbridge.com/en/quote/STAA.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [3 Stocks Riding The Smart Glasses And Eye Care Shift Investors Should Watch](https://longbridge.com/en/news/298212746.md)
- [STAAR Surgical Names Former CEO David Bailey as Chief Commercial Officer](https://longbridge.com/en/news/298497284.md)
- [STAAR report flags multi-market shift from laser to implantable lens vision correction](https://longbridge.com/en/news/298582351.md)
- [STAAR Surgical Names Former CEO David Bailey as Chief Commercial Officer | STAA Stock News](https://longbridge.com/en/news/298359527.md)
- [Should Earnings Outlook Require Action From First Solar (FSLR) Investors?](https://longbridge.com/en/news/298802715.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**